217 related articles for article (PubMed ID: 1320626)
1. Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus.
Padilla-Noriega L; Fiore L; Rennels MB; Losonsky GA; Mackow ER; Greenberg HB
J Clin Microbiol; 1992 Jun; 30(6):1392-7. PubMed ID: 1320626
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus.
Dunn SJ; Fiore L; Werner RL; Cross TL; Broome RL; Ruggeri FM; Greenberg HB
Arch Virol; 1995; 140(11):1969-78. PubMed ID: 7503695
[TBL] [Abstract][Full Text] [Related]
3. The VP5 domain of VP4 can mediate attachment of rotaviruses to cells.
Zárate S; Espinosa R; Romero P; Méndez E; Arias CF; López S
J Virol; 2000 Jan; 74(2):593-9. PubMed ID: 10623720
[TBL] [Abstract][Full Text] [Related]
4. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus.
Giammarioli AM; Mackow ER; Fiore L; Greenberg HB; Ruggeri FM
Virology; 1996 Nov; 225(1):97-110. PubMed ID: 8918537
[TBL] [Abstract][Full Text] [Related]
5. Location of intrachain disulfide bonds in the VP5* and VP8* trypsin cleavage fragments of the rhesus rotavirus spike protein VP4.
Patton JT; Hua J; Mansell EA
J Virol; 1993 Aug; 67(8):4848-55. PubMed ID: 8392619
[TBL] [Abstract][Full Text] [Related]
6. The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin.
Fiore L; Greenberg HB; Mackow ER
Virology; 1991 Apr; 181(2):553-63. PubMed ID: 1849677
[TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
Li Y; Xue M; Yu L; Luo G; Yang H; Jia L; Zeng Y; Li T; Ge S; Xia N
Vaccine; 2018 Apr; 36(16):2086-2092. PubMed ID: 29555220
[TBL] [Abstract][Full Text] [Related]
8. Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge.
Mackow ER; Vo PT; Broome R; Bass D; Greenberg HB
J Virol; 1990 Apr; 64(4):1698-703. PubMed ID: 2157052
[TBL] [Abstract][Full Text] [Related]
9. Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.
Flores J; Perez-Schael I; Blanco M; Vilar M; Garcia D; Perez M; Daoud N; Midthun K; Kapikian AZ
J Clin Microbiol; 1989 Mar; 27(3):512-8. PubMed ID: 2541168
[TBL] [Abstract][Full Text] [Related]
10. Rotavirus-specific breast milk antibody in two populations and possible correlates of interference with rhesus rotavirus vaccine seroconversion.
Rimer HC; Wasserman SS; Flores J; Pichichero ME; Losonsky GA
J Infect Dis; 1992 May; 165(5):826-30. PubMed ID: 1373753
[TBL] [Abstract][Full Text] [Related]
11. Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3.
Padilla-Noriega L; Dunn SJ; López S; Greenberg HB; Arias CF
Virology; 1995 Jan; 206(1):148-54. PubMed ID: 7530390
[TBL] [Abstract][Full Text] [Related]
12. Distribution of conserved and specific epitopes on the VP8 subunit of rotavirus VP4.
Larralde G; Gorziglia M
J Virol; 1992 Dec; 66(12):7438-43. PubMed ID: 1279204
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation.
Ludert JE; Ruiz MC; Hidalgo C; Liprandi F
J Virol; 2002 Jul; 76(13):6643-51. PubMed ID: 12050377
[TBL] [Abstract][Full Text] [Related]
14. Immunological response to recombinant VP8* subunit protein of bovine roravirus in pregnant cattle.
Lee J; Babiuk LA; Harland R; Gibbons E; Elazhary Y; Yoo D
J Gen Virol; 1995 Oct; 76 ( Pt 10)():2477-83. PubMed ID: 7595351
[TBL] [Abstract][Full Text] [Related]
15. Serotype-specific epitope(s) present on the VP8 subunit of rotavirus VP4 protein.
Larralde G; Li BG; Kapikian AZ; Gorziglia M
J Virol; 1991 Jun; 65(6):3213-8. PubMed ID: 1709699
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus specific breast milk antibody in two populations and possible correlates of protection.
Losonsky GA; D'Alessandra de Rimer H
Adv Exp Med Biol; 1991; 310():265-9. PubMed ID: 1667067
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.
Ruggeri FM; Greenberg HB
J Virol; 1991 May; 65(5):2211-9. PubMed ID: 1850007
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine.
Jalil F; Zaman S; Carlsson B; Glass RI; Kapikian AZ; Mellander L; Hanson LA
Trans R Soc Trop Med Hyg; 1991; 85(2):292-6. PubMed ID: 1653474
[TBL] [Abstract][Full Text] [Related]
19. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children.
Vesikari T; Kapikian AZ; Delem A; Zissis G
J Infect Dis; 1986 May; 153(5):832-9. PubMed ID: 3009634
[TBL] [Abstract][Full Text] [Related]
20. The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region.
Mackow ER; Shaw RD; Matsui SM; Vo PT; Dang MN; Greenberg HB
Proc Natl Acad Sci U S A; 1988 Feb; 85(3):645-9. PubMed ID: 2829198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
